Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Raised to $14 at Citi

February 27, 2025 3:04 PM
Citi analyst David Lebowitz raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $14.00 (from $12.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles